Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Senti Biosciences (SNTI) Change in Taxes (2021 - 2022)

Senti Biosciences has reported Change in Taxes over the past 2 years, most recently at -$113795.0 for Q1 2022.

For Q1 2022, Change in Taxes changed N/A year-over-year to -$113795.0; the TTM value through Mar 2022 reached $199558.0, changed N/A, while the annual FY2021 figure was $163839.0, N/A changed from the prior year.
Change in Taxes for Q1 2022 was -$113795.0 at Senti Biosciences, down from $163839.0 in the prior quarter.
Over five years, Change in Taxes peaked at $163839.0 in Q4 2021 and troughed at -$113795.0 in Q1 2022.